Cyclinac medical accelerators using pulsed C6+/H2+ ion sources

Charged particle therapy, or so-called hadrontherapy, is developing very rapidly. There is large pressure on the scientific community to deliver dedicated accelerators, providing the best possible treatment modalities at the lowest cost. In this context, the Italian research Foundation TERA is developing fast-cycling accelerators, dubbed `cyclinacs'. These are a combination of a cyclotron (accelerating ions to a fixed initial energy) followed by a high gradient linac boosting the ions energy up to the maximum needed for medical therapy. The linac is powered by many independently controlled klystrons to vary the beam energy from one pulse to the next. This accelerator is best suited to treat moving organs with a 4D multipainting spot scanning technique. A dual proton/carbon ion cyclinac is here presented. It consists of an Electron Beam Ion Source, a superconducting isochronous cyclotron and a high-gradient linac. All these machines are pulsed at high repetition rate (100–400 Hz). The source should deliver both C6+ and H2+ ions in short pulses (1.5 μs flat-top) and with sufficient intensity (at least 108 fully stripped carbon ions per pulse at 300 Hz). The cyclotron accelerates the ions to 120 MeV/u. It features a compact design (with superconducting coils) and a low power consumption. The linac has a novel C-band high-gradient structure and accelerates the ions to variable energies up to 400 MeV/u. High RF frequencies lead to power consumptions which are much lower than the ones of synchrotrons for the same ion extraction energy. This work is part of a collaboration with the CLIC group, which is working at CERN on high-gradient electron-positron colliders.

[1]  U. Amaldi.  CYCLINACS: NOVEL FAST-CYCLING ACCELERATORS FOR HADRONTHERAPY , 2007 .

[2]  A. G. Drentje,et al.  Review on heavy ion radiotherapy facilities and related ion sources (invited). , 2010, The Review of scientific instruments.

[3]  Mayer Ramona,et al.  Epidemiological aspects of hadron therapy: A prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO) , 2004 .

[4]  Saverio Braccini,et al.  High Frequency Linacs for Hadrontherapy , 2009 .

[5]  Hiroshi Asakura,et al.  Commissioning of a conformal irradiation system for heavy-ion radiotherapy using a layer-stacking method. , 2006, Medical physics.

[6]  J. V. Lebacqz,et al.  Breakdown phenomena in high-power klystrons , 1988 .

[7]  Huaizhou Zhao,et al.  Intense heavy ion beam production from IMP LECR3 and construction progress of a superconducting ECR ion source SECRAL , 2004 .

[8]  Hirotsugu Ogawa,et al.  Development of a compact electron-cyclotron-resonance ion source for high-energy carbon-ion therapy , 2005 .

[9]  Andrew J. Wroe,et al.  Proton Radiation Therapy in the Hospital Environment: Conception, Development, and Operation of the Initial Hospital-Based Facility , 2009 .

[10]  R. Becker.  Modern options for hadron therapy of tumors , 2006 .

[11]  Dejan Trbojevic.  FFAGs as Accelerators and Beam Delivery Devices for Ion Cancer Therapy , 2009 .

[12]  A. Lomax,et al.  Intensity modulation methods for proton radiotherapy. , 1999, Physics in medicine and biology.

[13]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[14]  E. Pedroni,et al.  The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. , 1995, Medical physics.

[15]  R. Becker,et al.  The Frankfurt MEDEBIS: A prototype of an injector for a synchrotron dedicated for cancer therapya) , 1996 .

[16]  Daniele Davino,et al.  LIBO—a linac-booster for protontherapy: construction and tests of a prototype , 2004 .

[17]  A. Trofimov,et al.  Physical and Biological Basis of Proton and of Carbon Ion Radiation Therapy and Clinical Outcome Data , 2009 .

[18]  M. Pullia,et al.  Progress of the Proton-Ion Medical Machine Study (PIMMS) , 1999, Strahlentherapie und Onkologie.

[19]  A. Coray,et al.  A NOVEL GANTRY FOR PROTON THERAPY AT THE PAUL SCHERRER INSTITUTE , 2002 .

[20]  A M Koehler,et al.  Flattening of proton dose distributions for large-field radiotherapy. , 1977, Medical physics.

[21]  A. Garonna.  SYNCHROCYCLOTRON PRELIMINARY DESIGN FOR A DUAL HADRONTHERAPY CENTER , 2010 .

[22]  E. Griesmayer,et al.  DRESDEN EBIS-SC - A NEW GENERATION OF POWERFUL ION SOURCES FOR THE MEDICAL PARTICLE THERAPY , 2007 .

[23]  G. Caporaso,et al.  The Dielectric Wall Accelerator , 2009 .

[24]  Nobuyuki Kanematsu,et al.  Evaluation of beam wobbling methods for heavy-ion radiotherapy. , 2008, Medical physics.

[25]  E. Donets.  Electron string phenomenon: physics and use , 2004 .

[26]  R. Wilson.  Radiological use of fast protons. , 1946, Radiology.

[27]  W. D. Kilpatrick,et al.  Criterion for Vacuum Sparking Designed to Include Both rf and dc , 1957 .

[28]  Ugo Amaldi.  The Italian hadrontherapy project , 1995 .

[29]  D. Schardt,et al.  Magnetic scanning system for heavy ion therapy , 1993 .

[30]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .

[31]  Walter Wuensch,et al.  New local field quantity describing the high gradient limit of accelerating structures , 2009 .

[32]  Ursula Nestle,et al.  Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.

[33]  Toshiki Tajima,et al.  Laser Acceleration of Ions for Radiation Therapy , 2009 .

[34]  Riccardo Zennaro,et al.  Accelerators for hadrontherapy: From Lawrence cyclotrons to linacs , 2010 .

[35]  P. Pommier,et al.  A "one-day survey": as a reliable estimation of the potential recruitment for proton- and carbon- ion therapy in France. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  Roberto Orecchia,et al.  Medical aspects of the National Centre For Oncological Hadrontherapy (CNAO-Centro Nazionale Adroterapia Oncologica) in Italy. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.